A single report of zebrafish B-ALL using transgenic ETV6-RUNX1 [19] had low penetrance and long latency (~3% by 1 year), and no subsequent reports with this or any other B-ALL model exist. This evidence concerns the gene RUNX1 and acute lymphoblastic leukemia.